398 studies found for:    Open Studies | "Ovarian Neoplasms"
Show Display Options
RSS Create an RSS feed from your search for:
Open Studies | "Ovarian Neoplasms"
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Recruiting Fenretinide/LXS Oral Powder Plus Ketoconazole in Recurrent Ovarian Cancer
Conditions: Ovarian Cancer;   Cancer of Ovary;   Cancer of the Ovary;   Ovary Neoplasms;   Primary Peritoneal Carcinoma
Intervention: Drug: Fenretinide/LXS + Ketoconazole
2 Recruiting Interactive Educational Website for Women With Ovarian Cancer & Caregivers
Conditions: Stage III Ovarian Cancer;   Stage IV Ovarian Cancer;   Recurrent Ovarian Cancer;   Primary Peritoneal Cancer;   Fallopian Tube Cancer
Interventions: Behavioral: Usual Care Educational Website;   Behavioral: Prototype System
3 Not yet recruiting Imaging Tumor Hypoxia With 18F-EF5 PET in Recurrent or Metastatic Clear Cell Ovarian Cancer
Conditions: Ovarian Cancer;   Ovarian Neoplasms
Interventions: Drug: 18F-EF5 PET/CT scan;   Procedure: Optional biopsy
4 Recruiting Phase Ib Study of Olaparib Plus Weekly Carboplatin and Paclitaxel in Relapsed Ovarian Cancer
Conditions: Stage III Ovarian Cancer;   Stage IV Ovarian Cancer;   Uterine Cancer
Interventions: Drug: Olaparib;   Drug: Carboplatin;   Drug: Paclitaxel
5 Recruiting A Crossover Bioequivalence Study of Intravenously Administered ATI0918 and DOXIL/CAELYX in Patients With Ovarian Cancer
Conditions: Ovarian Cancer;   Malignant Female Reproductive System Neoplasm;   Cancer;   Ovarian Tumor;   Ovarian Epithelial Cancer Recurrent
Interventions: Drug: DOXIL/CAELYX;   Drug: ATI-0918
6 Recruiting 18F-CP18 Imaging Studies for Cancer Treatment With Birinapant
Conditions: Ovarian Neoplasms;   Ovarian Cancer;   Fallopian Tube Neoplasms;   Fallopian Tube Cancer
Interventions: Drug: [18F]-CP18;   Procedure: PET/ CT
7 Not yet recruiting Cost of Cancer Risk Management in Women at Elevated Genetic Risk for Ovarian Cancer Who Participated on GOG-0199
Conditions: Fallopian Tube Cancer;   Hereditary Breast/Ovarian Cancer (brca1, brca2);   Ovarian Cancer;   Primary Peritoneal Cavity Cancer
Interventions: Other: medical chart review;   Other: study of socioeconomic and demographic variables;   Procedure: disease screening;   Procedure: evaluation of cancer risk factors;   Procedure: genitourinary surgical procedure;   Procedure: psychosocial assessment and care;   Procedure: quality-of-life assessment
8 Recruiting Specimen and Data Study for Ovarian Cancer Early Detection and Prevention
Conditions: Cervical Cancer;   Endometrial Cancer;   Fallopian Tube Cancer;   Hereditary Breast/Ovarian Cancer (brca1, brca2);   Ovarian Cancer;   Sarcoma;   Uterine Leiomyomata;   Vaginal Cancer;   Vulvar Cancer
Interventions: Other: laboratory biomarker analysis;   Other: screening questionnaire administration;   Procedure: study of high risk factors
9 Recruiting STELLA Trial: Transperitoneal vs. Extraperitoneal Approach for Laparoscopic Staging of Endometrial/Ovarian Cancer
Conditions: Endometrial Neoplasms;   Ovarian Neoplasms
Interventions: Procedure: Transperitoneal laparoscopic aortic lymphadenectomy;   Procedure: Extraperitoneal laparoscopic aortic lymphadenectomy
10 Recruiting Biobehavioral Influences and the Ovarian Tumor Microenvironment
Condition: Ovarian Neoplasms
Intervention:
11 Unknown  Neoadjuvant Chemotherapy With Carboplatin and Docetaxel in Patients With Advanced Ovarian Cancer-Prospective, Randomized Phase II Clinical Trial
Condition: Ovarian Neoplasms
Intervention: Procedure: neoadjuvant chemotherapy (Carboplatin/Docetaxel)
12 Recruiting Cancer Screening Program for Women at High Risk for Developing Ovarian Cancer
Conditions: Ovarian Diseases;   Ovarian Neoplasms
Interventions: Other: Laboratory Tumor Marker Analysis;   Other: Transvaginal Ultrasound;   Other: Health Status Questionnaire
13 Recruiting 89Zr-MMOT PET Imaging in Pancreatic and Ovarian Cancer Patients
Conditions: Ovarian Neoplasms;   Ovarian Diseases;   Adnexal Diseases;   Pancreatic Neoplasms;   Digestive System Neoplasms;   Digestive System Diseases;   Pancreatic Diseases
Intervention: Drug: 89Zr-MMOT0530A
14 Recruiting Activity, Tolerability, Safety of Temsirolimus in Women With Ovarian Cancer Who Progressed During Previous Platinum Chemotherapy or Within 6 Months After Therapy or Advanced Endometrial Carcinoma
Conditions: Genital Diseases, Female;   Ovarian Diseases;   Ovarian Neoplasms;   Endometrial Neoplasms
Intervention: Drug: Temsirolimus
15 Not yet recruiting Salvage Ovarian FANG Vaccine + Carboplatinum
Conditions: Stage III Ovarian Cancer;   Stage IV Ovarian Cancer
Interventions: Biological: Vaccine: FANG™ Vaccine;   Drug: Carboplatinum
16 Recruiting BIBF 1120 + Carboplatin/Pegylated Liposomal Doxorubicin (PLD) in Patients With Ovarian Cancer (OC)
Conditions: Ovarian Neoplasms;   Peritoneal Neoplasms
Interventions: Drug: BIBF 1120 + PLD 30 mg/m2 + CBDCA AUC5 mg/mL*min;   Drug: BIBF 1120+ PLD 30 mg/m2 + CBDCA AUC5 mg/mL*min
17 Recruiting M. D. Anderson Symptom Inventory - Ovarian Cancer
Condition: Ovarian Cancer
Interventions: Behavioral: Interview;   Behavioral: Survey
18 Recruiting AZD2281 Plus Carboplatin to Treat Breast and Ovarian Cancer
Conditions: Breast Cancer;   Ovarian Cancer
Interventions: Drug: AZ2281;   Drug: Carboplatin
19 Recruiting [18F]Fluciclatide-PET, Pazopanib and Paclitaxel in Ovarian Cancer
Condition: Ovarian Neoplasm
Intervention: Drug: Pazopanib and paclitaxel
20 Recruiting Data Collection for Patients With Low Grade Ovarian Carcinoma
Conditions: Ovarian Cancer;   Peritoneum Tumors
Intervention: Behavioral: Data Collection

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
Indicates status has not been verified in more than two years